Status:
RECRUITING
Non-Invasive Diagnostic Tests for MASLD in Pediatric Population
Lead Sponsor:
Emory University
Collaborating Sponsors:
Sonic Incytes
The Obesity Society
Conditions:
Metabolic Dysfunction Associated Steatotic Liver Disease
Non-Alcoholic Fatty Liver Disease (NAFLD)
Eligibility:
All Genders
2-20 years
Phase:
NA
Brief Summary
This study aims to test the utility of Velacur ultrasound as a non-invasive, rapid, point of care diagnostic tool for detecting the presence and amount of hepatic steatosis in children and adolescents...
Detailed Description
Non-Alcoholic Fatty Liver Disease (NAFLD) is currently the leading cause of liver disease in children. The name of NAFLD recently changed to metabolic dysfunction associated steatotic liver disease (M...
Eligibility Criteria
Inclusion
- Males and females age 2-20 years with suspicion of MASLD or presenting to liver clinic for evaluation of liver disease, including possible MASLD
- For participants choosing to do MRI they have to be able to undergo MRI without sedation
- Written/verbal informed consent from parent or legal guardian
- Written/verbal informed assent from the child when indicated by age
Exclusion
- Ascites
- Pregnancy
- Failure to give consent or assent
- Have an implanted electronic device such as pacemaker, neurostimulator, or cochlear implant
Key Trial Info
Start Date :
January 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06218589
Start Date
January 18 2024
End Date
January 31 2026
Last Update
October 10 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta (CHOA)
Atlanta, Georgia, United States, 30322
2
Emory Children's Center
Atlanta, Georgia, United States, 30322